CRG, Illumina partner for large-scale analysis of genetic variation and function

The Centre for Genomic Regulation (CRG) has recently signed a year-long collaboration agreement with Illumina, a leading developer and manufacturer of life sciences tools and integrated systems for large-scale analysis of genetic variation and function.

The agreement enables close collaboration between a research centre whose principal mission is the study of the genome and how it translates into characteristics that distinguish each individual, and an industry leader whose technology and products accelerate genetic analysis research and applications, paving the way for molecular medicine and ultimately transforming healthcare. 

"This is the first step in a joint working relationship which I believe could be very fruitful, and which opens the door to more applied collaborations in the field of genomics, including the study of genetic diseases", says Luis Serrano, director of the CRG.

In addition, the agreement is aligned with the centre's strategic direction to foster collaboration between companies in the sector and the CRG. These kinds of alliances, and partnerships with hospitals, other research institutes and patient associations, are exactly what the CRG hopes to foster, as they are essential in attracting private funding and the development of a new economic model based on knowledge and innovation.

To this end, the CRG demonstrates its commitment to research and finding innovative solutions in difficult times, always striving to advance knowledge for the benefit of society, public health and economic prosperity.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Illumina, Inc.. (2019, June 19). CRG, Illumina partner for large-scale analysis of genetic variation and function. News-Medical. Retrieved on October 31, 2024 from https://www.news-medical.net/news/20120328/CRG-Illumina-partner-for-large-scale-analysis-of-genetic-variation-and-function.aspx.

  • MLA

    Illumina, Inc.. "CRG, Illumina partner for large-scale analysis of genetic variation and function". News-Medical. 31 October 2024. <https://www.news-medical.net/news/20120328/CRG-Illumina-partner-for-large-scale-analysis-of-genetic-variation-and-function.aspx>.

  • Chicago

    Illumina, Inc.. "CRG, Illumina partner for large-scale analysis of genetic variation and function". News-Medical. https://www.news-medical.net/news/20120328/CRG-Illumina-partner-for-large-scale-analysis-of-genetic-variation-and-function.aspx. (accessed October 31, 2024).

  • Harvard

    Illumina, Inc.. 2019. CRG, Illumina partner for large-scale analysis of genetic variation and function. News-Medical, viewed 31 October 2024, https://www.news-medical.net/news/20120328/CRG-Illumina-partner-for-large-scale-analysis-of-genetic-variation-and-function.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
MLL, IBM and Illumina collaborate to build new cognitive technology prototype for improving leukemia treatment